Grace Therapeutics, Inc. (GRCE)
NASDAQ: GRCE · Real-Time Price · USD
3.070
-0.080 (-2.54%)
At close: Sep 15, 2025, 4:00 PM EDT
3.139
+0.069 (2.25%)
After-hours: Sep 15, 2025, 7:46 PM EDT
Grace Therapeutics Market Cap
Grace Therapeutics has a market cap or net worth of $42.45 million as of September 15, 2025. Its market cap has increased by 65.49% in one year.
Market Cap
42.45M
Enterprise Value
22.45M
1-Year Change
65.49%
Ranking
Category
Stock Price
3.07
Market Cap Chart
Since October 24, 2011, Grace Therapeutics's market cap has decreased from $87.20M to $42.45M, a decrease of -51.32%. That is a compound annual growth rate of -5.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 15, 2025 | 42.45M | 11.95% |
| Dec 31, 2024 | 37.92M | 39.61% |
| Dec 29, 2023 | 27.16M | 21.53% |
| Dec 30, 2022 | 22.35M | -59.95% |
| Dec 31, 2021 | 55.80M | 77.21% |
| Dec 31, 2020 | 31.49M | -84.94% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.14B |
| Johnson & Johnson | 428.83B |
| AbbVie | 385.71B |
| UnitedHealth Group | 319.26B |
| AstraZeneca | 247.84B |
| Novo Nordisk | 242.99B |
| Novartis AG | 240.09B |
| Abbott Laboratories | 232.75B |